Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis

Copyright © 2013 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 150(2014), 2 vom: 10. Feb., Seite 220-4
1. Verfasser: Janssen, Erin (VerfasserIn)
Weitere Verfasser: Tsitsikov, Erdyni, Al-Herz, Waleed, Lefranc, Gerard, Megarbane, Andre, Dasouki, Majed, Bonilla, Francisco A, Chatila, Talal, Schneider, Lynda, Geha, Raif S
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Atopic dermatitis; B cell DOCK8; Hyper-IgE; T cell; Biomarkers DOCK8 protein, human Guanine Nucleotide Exchange Factors
LEADER 01000naa a22002652 4500
001 NLM234629495
003 DE-627
005 20231224101659.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2013.12.006  |2 doi 
028 5 2 |a pubmed24n0782.xml 
035 |a (DE-627)NLM234629495 
035 |a (NLM)24440647 
035 |a (PII)S1521-6616(13)00335-5 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Janssen, Erin  |e verfasserin  |4 aut 
245 1 0 |a Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 08.04.2014 
500 |a Date Revised 21.10.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2013 Elsevier Inc. All rights reserved. 
520 |a DOCK8 deficiency is a primary immunodeficiency characterized by recurrent sinopulmonary infections, dermatitis with cutaneous infections, elevated serum IgE levels, eosinophilia, and a high incidence of food allergy. Given the seriousness of DOCK8 deficiency, it is important to recognize it early and initiate appropriate therapy. Diagnosis relies on examining DOCK8 protein expression and sequencing of the 48 exons in the DOCK8 gene, but these assays are not always readily available. A major problem facing clinicians is that DOCK8 deficiency shares many clinical and laboratory features with severe atopic dermatitis. Here, we have identified biomarkers routinely measured by flow cytometry on whole blood in clinical immunology laboratories that may be used in distinguishing DOCK8 deficiency from severe atopic dermatitis. The use of these biomarkers may help the clinician identify those patients who are most likely to have DOCK8 mutations and would benefit from further specialized diagnostic testing 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Research Support, U.S. Gov't, P.H.S. 
650 4 |a Atopic dermatitis; 
650 4 |a B cell 
650 4 |a DOCK8; 
650 4 |a Hyper-IgE; 
650 4 |a T cell; 
650 7 |a Biomarkers  |2 NLM 
650 7 |a DOCK8 protein, human  |2 NLM 
650 7 |a Guanine Nucleotide Exchange Factors  |2 NLM 
700 1 |a Tsitsikov, Erdyni  |e verfasserin  |4 aut 
700 1 |a Al-Herz, Waleed  |e verfasserin  |4 aut 
700 1 |a Lefranc, Gerard  |e verfasserin  |4 aut 
700 1 |a Megarbane, Andre  |e verfasserin  |4 aut 
700 1 |a Dasouki, Majed  |e verfasserin  |4 aut 
700 1 |a Bonilla, Francisco A  |e verfasserin  |4 aut 
700 1 |a Chatila, Talal  |e verfasserin  |4 aut 
700 1 |a Schneider, Lynda  |e verfasserin  |4 aut 
700 1 |a Geha, Raif S  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 150(2014), 2 vom: 10. Feb., Seite 220-4  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:150  |g year:2014  |g number:2  |g day:10  |g month:02  |g pages:220-4 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2013.12.006  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 150  |j 2014  |e 2  |b 10  |c 02  |h 220-4